In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-β1

Hee Seok Yang, Suk Ho Bhang, Il Kwon Kim, Tae Jin Lee, Jin Muk Kang, Dae Hee Lee, Soo Hong Lee, Ki Chul Hwang, Byung Soo Kim

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Bone marrow mononuclear cells (BMMNCs) can be used to treat patients with myocardial infarction, since BMMNCs can differentiate in vitro toward cardiomyogenic lineages when treated with transforming growth factor-β1 (TGF-β1). However, the in vitro cardiomyogenic differentiation culture process is costly and laborious, and the patients should wait during the culture period. In this study, we hypothesize that BMMNCs implanted in cardiomyogenically undifferentiated state to myocardial infarction site would differentiate cardiomyogenically in situ when exogenous TGF-β1 is delivered to the cell implantation site. Heparinconjugated poly(lactic-co-glycolic acid) nanospheres (HCPNs) suspended in fibrin gel were used as a TGF-β1 delivery system. BMMNCs were labeled with a green fluorescent dye (PKH67) and implanted into the infarction border zone of rat myocardium using fibrin gel containing HCPNs and TGF-β1. BMMNC implantation using fibrin gel and HCPNs without TGF-β1 served as a control. Four weeks after implantation, the expression of cardiomyogenic marker proteins by the implanted BMMNCs was dramatically greater in the TGF-β1 delivery group than in the control group. This method can significantly improve the stem cell therapy technology for myocardial regeneration, since it can remove in vitro cell culture step for cardiomyogenic differentiation prior to cell implantation.

Original languageEnglish
Pages (from-to)299-312
Number of pages14
JournalCell Transplantation
Volume21
Issue number1
DOIs
StatePublished - 2012

Keywords

  • Bone marrow mononuclear cells (BMMNCs)
  • Cardiomyogenic differentiation
  • Myocardial infarction
  • Transforming growth factor-β1 (TGF-β1)

Fingerprint

Dive into the research topics of 'In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-β1'. Together they form a unique fingerprint.

Cite this